A 23-month-old Baby with Spinal Muscular Atrophy Type 1, Received a New Lease of ... - Latest Tweet by IANS India
The latest Tweet by IANS India states, 'A 23-month-old baby with Spinal Muscular Atrophy Type 1, received a new lease of life with Swiss drugmaker Novartis coming forward to donate gene therapy costing Rs 16 crore.'
A 23-month-old baby with Spinal Muscular Atrophy (SMA) Type 1, received a new lease of life with Swiss drugmaker Novartis (@Novartis) coming forward to donate gene therapy costing Rs 16 crore. pic.twitter.com/JMl5TQhSw0— IANS (@ians_india) August 7, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)
(The above story first appeared on LatestLY on Aug 07, 2022 07:33 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
